These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12904097)

  • 21. Proceedings of the Second Congress of the International Society of Ocular Toxicology. Deidesheim, F.R.G., May 20-24, 1990.
    Lens Eye Toxic Res; 1990; 7(3-4):181-768. PubMed ID: 1983103
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings of the First Congress of the International Society of Ocular Toxicology. Toronto, Canada, June 1988.
    Lens Eye Toxic Res; 1989; 6(1-2):1-393. PubMed ID: 2577306
    [No Abstract]   [Full Text] [Related]  

  • 23. Ocular adverse effects associated with systemic medications : recognition and management.
    Santaella RM; Fraunfelder FW
    Drugs; 2007; 67(1):75-93. PubMed ID: 17209665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular toxicity associated with systemic drug therapy.
    Moorthy RS; Valluri S
    Curr Opin Ophthalmol; 1999 Dec; 10(6):438-46. PubMed ID: 10662249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse ocular effects to systemic drug therapy].
    Czakó C; Sándor G; Horváth H; Szepessy Z; Nagy ZZ; Kovács I
    Orv Hetil; 2020 Jun; 161(23):951-961. PubMed ID: 32453698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced toxic reactions in the eye: an overview.
    Abdollahi M; Shafiee A; Bathaiee FS; Sharifzadeh M; Nikfar S
    J Infus Nurs; 2004; 27(6):386-98. PubMed ID: 15586102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular toxicology update.
    Fraunfelder FT; Meyer SM
    Aust J Ophthalmol; 1984 Nov; 12(4):391-4. PubMed ID: 6397176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children.
    Tantikul C; Dhana N; Jongjarearnprasert K; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008; 26(2-3):77-82. PubMed ID: 19054924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
    Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
    Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adverse effects of commonly used systemic drugs on the human eye. II.
    Silverman HI
    Am J Optom Arch Am Acad Optom; 1972 Apr; 49(4):335-62. PubMed ID: 4503506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular side-effects of drugs.
    Willetts GS
    Br J Ophthalmol; 1969 Apr; 53(4):252-62. PubMed ID: 5781034
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dealing with adverse drug reactions in dentistry. Procedures on encountering adverse drug reactions and goal of the Swiss Pharmacovigilance system].
    Egger SS; Krähenbühl S; Schlienger RG
    Schweiz Monatsschr Zahnmed; 2005; 115(12):1209-18. PubMed ID: 16408825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
    Mulchandani R; Kakkar AK
    Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ocular side effects of glaucoma treatment agents].
    Ehongo A; Bremer F
    Bull Soc Belge Ophtalmol; 2007; (304):103-10. PubMed ID: 17718234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
    Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
    Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recording and assessment of medication errors : Experience of the Drug Commission of the German Medical Association].
    Köberle U; Stammschulte T; Gundert-Remy U; Pitzer M; Bräutigam K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Sep; 61(9):1066-1074. PubMed ID: 30022236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular and visual side effects of drugs--a reconsideration.
    Koetting JF
    J Am Pharm Assoc; 1975 Oct; 15(10):558-67, 596. PubMed ID: 1184916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.